Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 4 Flow chart of the MDS MSA Study Group aims

Published byFanny Gunardi Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 4 Flow chart of the MDS MSA Study Group aims"— Presentation transcript:

1 Figure 4 Flow chart of the MDS MSA Study Group aims
Figure 4 | Flow chart of the MDS MSA Study Group aims. The work programme of the International Parkinson and Movement Disorders Society multiple system atrophy (MDS MSA) Study Group is split into two parts: a basic and clinical research part and an educational part. Several work packages were developed in view of the ultimate goal: the development of novel therapies for patients with MSA. Krismer, F. & Wenning, G. K. (2017) Multiple system atrophy: insights into a rare and debilitating movement disorder Nat. Rev. Neurol. doi: /nrneurol

Download ppt "Figure 4 Flow chart of the MDS MSA Study Group aims"

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.
Nat. Rev. Neurol. doi:10/1038/nrneurol

Nat. Rev. Neurol. doi:10/1038/nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 4 Progression-free survival, according to treatment group

Figure 4 Progression-free survival, according to treatment group
Figure 3 Life expectancy at birth in all countries included

Figure 3 Life expectancy at birth in all countries included
Figure 2 The US Centers for Disease Control and

Figure 2 The US Centers for Disease Control and
Figure 4 Time course of the development of physiological changes

Figure 4 Time course of the development of physiological changes
Figure 4 Host damage from infection-related inflammatory

Figure 4 Host damage from infection-related inflammatory
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Overview of risk factors for Parkinson disease dementia

Figure 2 Overview of risk factors for Parkinson disease dementia
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 1 General framework of brain–computer interface (BCI) systems

Figure 1 General framework of brain–computer interface (BCI) systems
Figure 2 The new concept of prodromal RBD

Figure 2 The new concept of prodromal RBD
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Proportion of patients for whom NEDA

Figure 3 Proportion of patients for whom NEDA
Figure 5 Number of AHSCT procedures for

Figure 5 Number of AHSCT procedures for
Figure 4 Neuromyelitis optica spectrum disorder brain lesions

Figure 4 Neuromyelitis optica spectrum disorder brain lesions
Figure 4 Brainstem lesions and acute central vestibular syndrome

Figure 4 Brainstem lesions and acute central vestibular syndrome

Similar presentations

Ads by Google